349 related articles for article (PubMed ID: 32732334)
41. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
42. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
43. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
44. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
[TBL] [Abstract][Full Text] [Related]
45. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
Field JK; Duffy SW; Baldwin DR; Whynes DK; Devaraj A; Brain KE; Eisen T; Gosney J; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rassl DM; Rintoul RC; Screaton NJ; Wald NJ; Weller D; Williamson PR; Yadegarfar G; Hansell DM
Thorax; 2016 Feb; 71(2):161-70. PubMed ID: 26645413
[TBL] [Abstract][Full Text] [Related]
46. Psychological impact of lung cancer screening using a novel antibody blood test followed by imaging: the ECLS randomized controlled trial.
Hancox J; Ayling K; Bedford L; Vedhara K; Roberston JFR; Young B; das Nair R; Sullivan FM; Schembri S; Mair FS; Littleford R; Kendrick D
J Public Health (Oxf); 2023 Jun; 45(2):e275-e284. PubMed ID: 35285902
[TBL] [Abstract][Full Text] [Related]
47. Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts.
Trudgen K; Khattar NH; Bensadoun E; Arnold S; Stromberg AJ; Hirschowitz EA
PLoS One; 2014; 9(2):e87947. PubMed ID: 24498409
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
49. Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Cramer JD; Grauer J; Sukari A; Nagasaka M
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1071-1078. PubMed ID: 34709369
[TBL] [Abstract][Full Text] [Related]
50. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.
Hazelton WD; Goodman G; Rom WN; Tockman M; Thornquist M; Moolgavkar S; Weissfeld JL; Feng Z
Math Biosci; 2012 Nov; 240(1):20-34. PubMed ID: 22705252
[TBL] [Abstract][Full Text] [Related]
51. Lung cancer stage-shift following a symptom awareness campaign.
Kennedy MPT; Cheyne L; Darby M; Plant P; Milton R; Robson JM; Gill A; Malhotra P; Ashford-Turner V; Rodger K; Paramasivam E; Johnstone A; Bhartia B; Karthik S; Foster C; Lovatt V; Hewitt F; Cresswell L; Coupland VH; Lüchtenborg M; Jack RH; Moller H; Callister MEJ
Thorax; 2018 Dec; 73(12):1128-1136. PubMed ID: 29950525
[TBL] [Abstract][Full Text] [Related]
52. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
[TBL] [Abstract][Full Text] [Related]
53. Contamination during 4 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST).
Saghir Z; Ashraf H; Dirksen A; Brodersen J; Pedersen JH
Lung Cancer; 2011 Mar; 71(3):323-7. PubMed ID: 20619924
[TBL] [Abstract][Full Text] [Related]
54. Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.
Roth JA; Sullivan SD; Goulart BH; Ravelo A; Sanderson JC; Ramsey SD
J Oncol Pract; 2015 Jul; 11(4):267-72. PubMed ID: 25943596
[TBL] [Abstract][Full Text] [Related]
55. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
56. The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.
Usher-Smith JA; Godoy A; Burge SW; Burbidge S; Cartledge J; Crosbie PAJ; Eckert C; Farquhar F; Hammond D; Hancock N; Iball GR; Kimuli M; Masson G; Neal RD; Rogerson S; Rossi SH; Sala E; Smith A; Sharp SJ; Simmonds I; Wallace T; Ward M; Callister MEJ; Stewart GD
BMJ Open; 2022 Sep; 12(9):e063018. PubMed ID: 36127097
[TBL] [Abstract][Full Text] [Related]
57. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study.
de-Torres JP; Casanova C; Marín JM; Zagaceta J; Alcaide AB; Seijo LM; Campo A; Carrizo S; Montes U; Cordoba-Lanus E; Baz-Dávila R; Aguirre-Jaime A; Celli BR; Zulueta JJ
Respir Med; 2013 May; 107(5):702-7. PubMed ID: 23465176
[TBL] [Abstract][Full Text] [Related]
58. Surgery for limited-stage small-cell lung cancer.
Barnes H; See K; Barnett S; Manser R
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011917. PubMed ID: 28429473
[TBL] [Abstract][Full Text] [Related]
59. Increased Disparities in Patients Diagnosed with Metastatic Lung Cancer Following Lung CT Screening in the United States.
Ganesh A; Katipally R; Pasquinelli M; Feldman L; Spiotto M; Koshy M
Clin Lung Cancer; 2022 Mar; 23(2):151-158. PubMed ID: 34924304
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
